SRP-9005

· Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRP-9005, covering 2025-08-06 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants [Phase 3]